SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Kura Oncology stock is trading sharply higher this morning after revealing the results of a Phase 2 trial of one of its cancer drugs, Tipifarnib.
Medtech giant Illumina Inc. announced a partnership with Oregon-based tech firm FlowJo LLC to develop and co-market software for analyzing single-cell, next-generation sequencing data.
San Diego drugmaker Acadia Pharmaceuticals Inc. is looking to raise $200 million in a secondary offering.
Scintilla Pharmaceuticals Inc., a subsidiary of San Diego’s Sorrento Therapeutics Inc., is acquiring a Pennsylvania-based pharmaceutical company focused on pain management.
San Diego biotech MEI Pharma signed a major deal with Swiss pharmaceutical group Helsinn that could be worth up to $464 million.
San Diego’s Orexigen Therapeutics Inc. reported a jump in quarterly revenue, but missed Wall Street’s expectations for total earnings-per-share, according to a recent earnings statement.
AMN Healthcare Inc. reported a 35 percent increase in revenue compared with the like quarter of the previous year in its second-quarter earnings report released Aug. 4.
Biotech veteran David Hale, who has been involved in San Diego’s life science industry for decades, has launched a new company, Adigica Health, Inc., to develop and commercialize specialty healthcare and skincare products directly to consumers.
MEDICINE: Blue Shield Rate Increase to Average 20%
Scripps Health’s reputation for inspiring loyalty among patients may soon be put to the test as its sole partner in the state-run insurance exchange, Blue Shield of California, plans a rate increase dwarfing those of its closest rivals in the highly competitive San Diego market.
La Jolla-based Ambrx Inc. has raised $45 million in new cash.
Carlsbad drugmaker Ionis Pharmaceuticals Inc. has received $75 million from its partner Biogen following news of positive Phase 3 data for its spinal muscular atrophy drug called Nusinersen.
AMN Healthcare announced it has appointed a former senior executive at McKesson Corp., Matt Zubiller, to lead strategic planning across all divisions of the San Diego-based workforce solutions and staffing services company.
Medical imaging software developer StatRad said Tuesday it has received a $13 million equity investment from an undisclosed institutional partner active in health care information technology.
San Diego biotech Evofem Inc. has raised $25 million in a Series D round.
Organovo Holdings Inc., the San Diego firm that “bioprints” three-dimensional human tissue, has appointed Craig Kussman as chief financial officer.